Skip to main content
. 2017 Nov 5;41:226–229. doi: 10.1016/j.ijscr.2017.10.034

Table 1.

Ovarian cancer present in cases of corpus cancer in our cancer database.

Case No. Age Corpus cancer
Ovarian cancer
Chemotherapy (1st line) Operation
Histology FIGO stage Histology FIGO stage
1a 51 EA, G1 IB EA, G1b IA TC TAH + BSO
2 51 EA, G1 IA EA, G1 IC(a) TC TAH + BSO
3 53 EA, G1 IA EA,G1 IA TC TAH + BSO + PLN + PAN + POM
4 44 EA, G1 IA EA,G1b IA TAH + BSO
5 45 EA, G3 IB EA,G2 IIIA TC TAH + BSO + POM
6 74 EA or MA IIIA EA or MA IIC(b) ddTC TAH + BSO
7 49 EA, G1 IA MA IC1 TAH + BSO + POM + APE
8 62 EA, G1 IA mucinous borderline tumor intestinal type IA TAH + BSO
9 48 EA, G1 IA serous borderline adenofibroma IC3 TAH + BSO + POM

EA: Endometrial adenocarcinoma, MA: Mucinous adenocarcinoma, TC: paclitaxel and carboplatin, ddTC: dose dense TC, TAH: Total abdominal hysterectomy, BSO: Bilateral salpingo-oophorectomy, PLN: Pelvic lymphadenectomy, PAN: Para-aortic lymphadenectomy, POM: Partial omentectomy, APE: Appendectomy

a

present patient.

b

ovarian endometriosis.